Adma Biologics Inc’s filing revealed that its CFO and Treasurer Tade Brad L. unloaded Company’s shares for reported $0.32 million on Nov 22 ’24. In the deal valued at $21.15 per share,15,000 shares were sold. As a result of this transaction, Tade Brad L. now holds 199,433 shares worth roughly $3.68 million.
Then, Grossman Adam S sold 48,967 shares, generating $1,033,204 in total proceeds. Upon selling the shares at $21.10, the President and CEO now owns 1,989,007 shares.
Before that, Grossman Adam S bought 48,967 shares. Adma Biologics Inc shares valued at $1,042,997 were divested by the Director and Officer at a price of $21.30 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Friday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 2.62% to $18.44. Over the last five days, the stock has gained 3.07%. Adma Biologics Inc shares have risen nearly 7.52% since the year began. Nevertheless, the stocks have risen 317.19% over the past one year. While a 52-week high of $23.64 was reached on 01/03/25, a 52-week low of $4.37 was recorded on 01/02/25. SMA at 50 days reached $19.07, while 200 days put it at $14.05.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 18.08, which if violated will result in even more drops to 17.72. On the upside, there is a resistance level at 18.64. A further resistance level may holdings at 18.84. The Relative Strength Index (RSI) on the 14-day chart is 49.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.48%. Stochastics %K at 37.04% indicates the stock is a holding.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2024-12-13, dropping by -2.06 million shares to a total of 12.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 14.24 million shares. There was a decline of -16.93%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
